Vanguard High Dividend Yield ETF (NYSEARCA:VYM) has become one of the largest income vehicles in the market, with $94.6 billion in net assets per its most recent NPORT filing. VYM tracks the FTSE High Dividend Yield Index, screening large-cap U.S. stocks with above-average forecast yields and weighting them by market cap. With the 10-year Treasury near 4.62%, the question is whether VYM’s distribution stream still earns its equity risk premium. The short answer: mostly yes, with two holdings worth watching.
How VYM Generates Income
VYM owns roughly 550 U.S. stocks and passes through their cash dividends, minus a thin expense ratio. There are no options, leverage, or bond exposure, so the distribution is only as safe as the underlying payouts. The index rebalances annually, pruning dividend-cutters and adding higher-yielders, giving the fund self-cleaning ability but no immunity to a bad quarter.
Concentration is meaningful at the top. Broadcom alone sits at about 8% of assets, followed by JPMorgan near 3%, Exxon near 3%, and Johnson & Johnson near 2%. The next tier includes Caterpillar, AbbVie, Bank of America, Home Depot, Chevron, and Cisco. That top ten drives the majority of VYM’s cash yield.
The Blue-Chip Core Is Doing Its Job
Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) raised its quarterly payout from $1.30 to $1.34 in Q2 2026, extending its Dividend King streak. With trailing EPS of $8.63 against an annualized dividend near $5.36, coverage is comfortable, and management raised full-year adjusted EPS guidance despite biosimilar erosion in Stelara. This dividend would survive a recession.
Procter & Gamble (NYSE:PG) lifted its quarterly dividend to $1.0885, marking another consecutive annual raise. Free cash flow of roughly $3 billion a quarter easily funds the payout, with $6.84 in diluted TTM EPS supporting $4.23 in dividends.
Coca-Cola (NYSE:KO) raised its dividend to $0.53 for 2026, a 63-plus-year streak. Q1 free cash flow jumped 131.9% year over year, and management guides to about $12.2 billion in 2026 FCF. This payout faces no realistic near-term risk.
AbbVie (NYSE:ABBV) is more interesting. Humira revenue fell 38.6% to $688 million last quarter, but Skyrizi and Rinvoq now generate a combined $6.6 billion per quarter with strong double-digit growth. Full-year adjusted EPS guidance was raised to $14.08 to $14.28, giving roughly 2x coverage on the $6.92 annualized dividend. The GAAP payout ratio looks stressed because of IPR&D charges, but the cash story is fine. (For investors thinking about high-yield warning signs elsewhere in their portfolios, our dividend traps briefing is worth a look.)
Two Positions Worth Watching
AT&T (NYSE:T) has held its quarterly dividend at $0.2775 for four consecutive years, and the stock is down about 18% over the past year. Management guides to $18 billion or more in 2026 FCF, but net debt/EBITDA at 2.71x remains above the 2.5x target. The dividend is safe. Dividend growth is not.
American Electric Power (NASDAQ:AEP) nudged its quarterly payout to $0.95, but the story is a $78 billion five-year capex plan and a $2.6 billion equity offering to fund it. Data-center load growth supports the plan, but dilution keeps per-share dividend growth in the low single digits.
Total Return and Verdict
VYM has delivered a 21.6% total return over the past year and 76.6% over five years, so investors have not sacrificed capital appreciation for yield. The distribution is well-supported: the top holdings are Dividend Kings with strong free cash flow, and even weaker names can cover their current payouts. The realistic risk is stagnant dividend growth from a few holdings. VYM makes sense for investors who want a diversified, low-fee income stream backed by real cash earnings. Yield-chasers looking for higher headline payouts should look elsewhere, because VYM is built for durability.
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks